Kratom lawsuit claims center on serious health risks and fatal overdoses linked to kratom products that have been sold across the United States in powders, capsules, extracts, and drink formulations
GLP-1 RAs are being studied [archived link] for use in many other medical conditions, including fatty liver disease, Parkinsons disease, and substance use disorders, among others
However, GLP-1 receptor agonists like semaglutide and liraglutide may delay gastric emptying, which could theoretically affect the absorption of oral medications including levothyroxine
(19) Clinical Studies Two randomized control trials studied the effect of GLP-1 receptor agonists on BMD, bone mineral content (BMC), and osteogenic markers
Theyre also pushing for plaintiffs to disclose information about unfiled cases, but that is not legally required